Quantum metrology of pump–probe spectroscopy
The Journal of Chemical Physics · 07.05.2026 · 164 (17)
DOI: 10.1063/5.0323961 ↗Kurz gefasst
Fachartikel in der Zeitschrift The Journal of Chemical Physics, online erschienen am 04.05.2026. Verfasst von Frank Schlawin. Beteiligte Einrichtung: Max Planck Institute for the Structure and Dynamics of Matter, Hamburg, Germany; University of Hamburg, Hamburg, Germany; and The Hamburg Centre for …. Die Arbeit nennt 64 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: Deutsche Forschungsgemeinschaft.
Abstract (Originalsprache)
Pump–probe spectroscopies form an irreplaceable tool for the investigation of ultrafast dynamics and energy relaxation. The extent to which they can benefit from new quantum technologies is an open question and a very active field of research. To provide a solid theoretical foundation for this research, here we formulate the measurement of a molecular relaxation rate with a two-pulse experiment as a parameter estimation problem. We derive a quantum map for the light fields and use it to investigate possible enhancement by the use of squeezed quantum states of light and pump–probe entanglement in the impulsive limit.
Autor:innen und Institutionen
- Max Planck Institute for the Structure and Dynamics of Matter, Hamburg, Germany; University of Hamburg, Hamburg, Germany; and The Hamburg Centre for Ultrafast Imaging, Hamburg, Germany.
ORCID-Profile: Frank Schlawin
Förderung
- Deutsche Forschungsgemeinschaft
Zitieren
APA
Schlawin, F. (2026). Quantum metrology of pump–probe spectroscopy. The Journal of Chemical Physics, 164(17). https://doi.org/10.1063/5.0323961
Vancouver
Schlawin F. Quantum metrology of pump–probe spectroscopy. The Journal of Chemical Physics. 2026;164(17). doi:10.1063/5.0323961
BibTeX
@article{Schlawin2026,
author = {Schlawin, Frank},
title = {Quantum metrology of pump–probe spectroscopy},
journal = {The Journal of Chemical Physics},
year = {2026},
volume = {164},
number = {17},
doi = {10.1063/5.0323961}
}
EUVIMED